2026 NPPES data Optometrist NPI 1174669873 O.D.
Verify on CMS →

JILBER FOULADIAN, O.D.

Optometrist in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
99
Medicare Part D claims · 40 beneficiaries · Optometrist avg: 257
Generic prescribing
19%
generic claims · 81% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$716.44
17 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JILBER FOULADIAN, O.D. filed 99 Medicare Part D claims in 2023 as a Optometrist in LOS ANGELES, California, prescribing 19% generic.

99
Part D claims, 2023
19%
generic prescribing
$716.44
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JILBER FOULADIAN, O.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

99 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about JILBER FOULADIAN, O.D.?

Quality data not reported

NPI registry status

Active

Issued 01/29/2007

NPI 1174669873

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

99 61% vs specialty avg

2023 prescription claims

Specialty avg: 257

Specialty distribution in California

How Optometrist compares to other specialties among California providers

California providers

Optometrist share within California

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Optometrist ABMS/AOA estimate

Est. board-certified rate (Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JILBER FOULADIAN, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 1312 WESTWOOD BLVD, LOS ANGELES, CA, 90024, with a listed phone of (310) 234-8900. NPI 1174669873 was issued on 01/29/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FOULADIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 99 prescription claims written by this provider, covering 40 Medicare beneficiaries and totaling roughly $49K in drug spend, split 81% brand-name and 19% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1312 WESTWOOD BLVD
LOS ANGELES, CA 90024

Provider Details

NPI 1174669873
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 01/29/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JILBER FOULADIAN, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$716

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JILBER FOULADIAN, O.D.. To verify JILBER FOULADIAN, O.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JILBER FOULADIAN, O.D. — brand share 81.0%
Specialty average (est.)

81% brand-name claims vs 19% generic, on 99 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

99
Total Claims
$49K
Total Drug Cost
40
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
105
Total Day Supply
2,798
Brand vs Generic
81% brand / 19% generic
Brand Drug Cost
$49K
Generic Drug Cost
$356

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
0.92

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JILBER FOULADIAN, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Restasis
Cyclosporine
35
Cyclosporine
23
Xiidra
Lifitegrast
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How JILBER FOULADIAN, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

JILBER FOULADIAN, O.D.'s 99 claims are below the specialty average of 257.

Nearby Optometrist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FOULADIAN.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JILBER FOULADIAN, O.D.'s specialty?
JILBER FOULADIAN, O.D. specializes in Optometrist and practices in LOS ANGELES, California. Credentials: O.D..
How much does JILBER FOULADIAN, O.D. prescribe under Medicare Part D?
In 2023, JILBER FOULADIAN, O.D. wrote 99 Medicare Part D claims totaling $49K in drug costs for 40 beneficiaries.
Where is JILBER FOULADIAN, O.D. located?
JILBER FOULADIAN, O.D. is located at 1312 WESTWOOD BLVD, LOS ANGELES, CA, 90024. Phone: (310) 234-8900.
What is JILBER FOULADIAN, O.D.'s NPI number?
JILBER FOULADIAN, O.D.'s National Provider Identifier (NPI) is 1174669873, issued on 01/29/2007.
Does JILBER FOULADIAN, O.D. prescribe more brand-name or generic drugs?
JILBER FOULADIAN, O.D.'s prescribing is 81% brand-name and 19% generic drugs by claim count, with $49K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does JILBER FOULADIAN, O.D. prescribe most often?
Based on 2023 Medicare Part D data, JILBER FOULADIAN, O.D.'s most frequently prescribed drugs include Restasis, Cyclosporine, Xiidra. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JILBER FOULADIAN, O.D. accept Medicare?
JILBER FOULADIAN, O.D. appears in CMS Medicare data with 99 Part D claims and 40 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JILBER FOULADIAN, O.D.'s credentials?
JILBER FOULADIAN, O.D.'s NPI is 1174669873 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology